Fifth, while our GDM model was based on a well-validated protocol and hyperglycemia was confirmed at the time of model induction, we did not perform longitudinal profiling of peripheral metabolic parameters such as plasma insulin, glucose tolerance, or asprosin levels. This evidence concerns the gene FBN1 and gestational diabetes.